ABBV
AbbVie
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 153.66B; Volume: 2.60M; AvgVol 3m: 6.87M; Beta: 0.71;
Cost estimate:
P/E: –; EPS: 4.55; EPS growth quarter/prev quarter: -192.90%;
EPS growth this year: 42.30%; EPS growth past 5 years: 36.80%;
EPS ttm: 4.55;
P/S: 4.23; P/B: 9.62; P/Cashflow: 25.39; P/FCF: 20.69;
Sales: 36.23B; Sales growth quarter/prev quarter: 26.30%; Sales growth past 5 years: 10.80%;
Profitability:
Gross Margin: 73.30%; Profit Margin: 19.10%; Operating Margin: 30.20%;
ROA – return on assets: 7.10%; ROE – return on equity: -303.40%; LT Debt/Equity: 5.58; Total Debt/Equity: 5.94;
Dividend: 4.72; Dividend Yield (%): 5.39%;
Insider Ownership: 0.10%; Insider Transactions:-5.09%;
Institutional Ownership: 70.80%; Institutional Transactions: 12.52%;
Data update: 07.10.2020.